In experimental stroke, pharmacological augmentation of recovery is dependent on enriched environment and stimulation–hence the rationale for combining G-CSF and physiotherapy.[20] We hypothesised that in chronic stroke intensive therapy can stimulate use dependent plasticity, which may be augmented by G-CSF. This evidence concerns the gene CSF3 and stroke disorder.